Differential expression of efferocytosis and phagocytosis associated genes in tumor associated macrophages exposed to African American patient derived prostate cancer microenvironment

Abstract

Macrophages are the first line of defense in the cellular environment in response to any antigenic or foreign invasion. Since cancer cells express antigenic molecules and create a tumor microenvironment quite different from the normal cellular environment, macrophages will attack this cancer cells as foreign Invaders. However, the cancer cells adept their ability to suppress macrophage activity by secreting compounds/proteins through unknown mechanisms and train these macrophages to aid in tumorigenesis. These macrophages are commonly known as tumor associated macrophages (TAM). In this study, our goal was to find out key regulatory molecules involved in this conversion of cancer-fighting macrophages to cancer friendly macrophages. We used African American(AA) patient derived established human prostate cancer cells along with the human derived macrophages followed by Affymetrix cDNA microarray analysis. Microarray analysis of the PCa cell exposed macrophages revealed appreciable decrease in mRNA expression of several genes associated with phagocytosis process. Aberrant expression of several noncoding RNAs that control the expression of such phagocytosis associated molecules were also evident. Increased expression of oncogenic miR such as, miR-148, 615, 515, 130, 139 and markedly decreased expression of tumor suppressive miR’s MiR-3130, let7c,101,103, 383 were noted. Further, TARGET SCAN analysis demonstrated these differential expression of non-coding RNA’s causing down regulation of phagocytosis promoting genes elf5A, Meg3, Tubb5, Sparcl-1, Uch-1, Bsg(CD147), Ube2v, GULP, Stabilin 1 and Pamr1. There is an increase of RAP1GAP gene that causes concomitant decrease in the expression of tubulin genes that promote cytoskeletal assembly in forming phagosomes. In addition Ingenuity pathway analysis of the gene expression data also showed upregulation of antiphagocytic genes IL-10, CD16, IL-18 and MMP-9. Some core canonical pathways showing physiology of cellular signaling obtained by data analyzed by the Ingenuity software is confirmed a very complex mechanism still to be deciphered involved in the biology of TAM formation by which the rogue cancer cells tame their enemies, the macrophages and actually make them their helper cells to survive and propagate in the tumor microenvironment and thus prepare for epithelial mesenchymal transition for future metastasis and cancer stem cell formation and progression.

Keywords

Tumor associated macrophages / Tumor microenvironment / Core canonical pathways

References

[1] Yoshihiro K, Yukio F, Koji O, et al. Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. Advanced Drug Delivery Reviews. 2016 April; 99 (Pt B): 180-185. PMid:26621196. https://doi.org/10.1016/j.addr.2015.11.009

[2] Renato O, Kratochvill, Franz K, et al. Macrophages and cancer: from mechanisms to therapeutic implications. Trends in Immunology. 2015 April; 36(4): 229-239. PMid:25770924. https://doi.org/10.1016/j.it.2015.02.004

[3] Bin ZQ, Jeffrey WP. Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell. 2010 April; 141(1): 39-51. PMid:20371344. https://doi.org/10.1016/j.cell.2010.03.014

[4] Alberto M, Federica M, Alberto M, et al. Tumour-associated macrophages as treatment targets in oncology. Nature Reviews Clin-ical Oncology. 2017 January; 14(7): 399-416. PMid:28117416. https://doi.org/10.1038/nrclinonc.2016.217

[5] Vladimir R, Alexandru G, Nan W, et al. Role of tumor asso-ciated macrophages in tumor angiogenesis and lymphangiogene-sis. Frontiers in Physiology. 2014 March; 5: 75. PMid:24634660. https://doi.org/10.3389/fphys.2014.00075

[6] Roy N, Jeffrey WP. Tumor-Associated Macrophages: From Mechanisms to Therapy. Immunity. 2014 July; 41(1): 49-61. PMid:25035953. https://doi.org/10.1016/j.immuni.2014.06.010

[7] Doedens AL, Stockmann C, Rubinstein MP, et al. Macrophage Ex-pression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression. Cancer Research. 2010 September; 70(19): 7465-7475. PMid:20841473. https://doi.org/10.1158/0008-5472.CAN-10-1439

[8] Fernando OM, Siamon G. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Reports. 2014 March; 6: 13. PMid:24669294. https://doi.org/10.12703/P6-13

[9] Allavena P, Sica A, Solinas G, et al. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Critical Reviews in Oncology/Hematology. 2018; 66(1): 1-9. PMid:17913510. https://doi.org/10.1016/j.critrevonc.2007.07.004

[10] Cruz ML, Barco SA, Henao CF, et al. New insights into the role of the immune microenvironment in breast carcinoma. Dev Immunol. 2013; 2013: 785317. PMid:23861693. https://doi.org/10.1155/2013/785317

[11] Carly BW, Elizabeth SY, Adam CS. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. Npj Breast Can-cer. 2016; 2(1). PMid:26998515. https://doi.org/10.1038/npjbcancer.2015.25

[12] Zou W, Wolchok JD, Chen L. PD-L 1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016; 8: 328rv4. PMid:26936508. https://doi.org/10.1126/scitranslmed.aad7118

[13] Soo RA, Stone ECA, Cummings KM, et al. Scientific Advances in Thoracic Oncology 2016. J Thorac Oncol. 2017; 12: 1183-209.

[14] Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus Do-cetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Can-cer. N Engl J Med. 2015; 373: 123-35. PMid:26028407. https://doi.org/10.1056/NEJMoa1504627

[15] Banerjee H, Bazemore B, Barfield A, et al. A Study to Investigate the Role of GULP/ CED 6 Gene in Eat Me Signaling in Cellular Ef-ferocytosis and Immunosurveillance. Immunol Disord Immunother. 2016 Dec; 1(3). pii: 109.

[16] Banerjee HN, Vaughan D, Boston A, et al. The Effects of Synthesized Rhenium Acetylsalicylate Compounds on Human Astrocytoma Cell Lines. J Cancer Sci Ther. 2018; 10(2). pii: 512. PMid: 29707104. https://doi.org/10.4172/1948-5956.1000512